Category Archives: 43rd_district

Omeros receives support for clinical study from National Institute on Drug Abuse

Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced that “the National Institute on Drug Abuse (NIDA) is providing support for the Company’s Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be … Continue reading

Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle | Leave a comment

Omeros stock IPO closes lower in first two days of trading

Omeros Corporation, a Seattle-based biopharmaceutical company, saw its stock price close lower in its first two days of trading after the company’s initial public offering (IPO) on October 8, 2009. The company had priced its offering of 6.82 million shares … Continue reading

Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle | Leave a comment

Theo Chocolate, UW scientists to identify the best organic cocoa beans

Xconomy’s interview with Theo’s chief operating officer and food scientist, Dr. Andy McShea, describes Theo’s partnership with University of Washington to develop food quality-analysis technology. Related external links (will open a new window): More in Xconomy Related WTC links: Theo … Continue reading

Posted in 43rd_district, Company_and_Client_News, Life_Sciences, RTD, Seattle, Theo_Chocolate, UW | Leave a comment

Omeros awarded $465,000 grant for Parkinson’s research

Omeros Corporation, a Seattle-based biopharmaceutical company, has been awarded a $465,000 grant from The Michael J. Fox Foundation to evaluate Omeros’ recent dicovery of a new target for the treatment of Parkinson’s disease. Related external links (will open a new … Continue reading

Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle | Leave a comment